Antimicrobial resistance and ecological disruption caused by broad-spectrum disinfectants have created an urgent need for ...
TipRanks on MSN
XORTX highlights new gout genetics research, reshapes board and clarifies financing as Vectus deal nears closing
The latest announcement is out from XORTX Therapeutics Inc ( ($TSE:XRTX) ). On December 31, 2025, XORTX Therapeutics highlighted newly published, ...
TipRanks on MSN
XORTX leans into genetic breakthroughs in gout as it reshapes board and advances oxypurinol
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has shared an announcement. XORTX Therapeutics highlighted newly published, large-scale genetic research ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback